S3 | E35 | AI-driven vocal biomarkers and the future of clinical diagnostics - Henry @ Canary Speech
Today I’m joined by Henry O’Connell, CEO & Founder of Canary Speech, the company pioneering AI-powered vocal biomarkers to detect diseases like Alzheimer’s, Parkinson’s, and other neurological and behavioural conditions, all through a 20–30 second voice sample.
In this episode, we explore:
How Canary Speech was founded and where the idea came from
Why holding 14 patents in vocal biomarker technology is such a competitive advantage
How Canary ensures clinical-grade safety, trust, and bias mitigation in AI healthcare tools
The latest innovations in aggression detection, neurological disorders &…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.